Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3))
Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A3065 |
Sku # | A3065-1mg*25 |
Pricing | 1mg*25, $5070.00 |